EBV

Clinical trials for EBV explained in plain language.

Never miss a new study

Get alerted when new EBV trials appear

Sign up with your email to follow new studies for EBV, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet recruiting 1 Completed 1

New mRNA vaccine targets Epstein-Barr virus in first human trial

⭐️ VACCINE ⭐️ Not yet recruiting

This early-stage trial is testing a new mRNA vaccine called VXCO-102 against Epstein-Barr virus (EBV) in 45 healthy adults aged 18 to 25. The main goal is to check if the vaccine is safe and triggers an immune response. EBV is a common virus that can cause mononucleosis and is li…

Matched conditions: EBV

Phase: PHASE1 • Sponsor: Vaccine Company, Inc. • Aim: ⭐️ VACCINE ⭐️

Last updated Jun 27, 2026 12:25 UTC

EBV

Get alerted when new EBV trials appear

New mRNA vaccine targets Epstein-Barr virus in first human trial